Literature DB >> 27408360

Mixed Phenotypic Acute Leukemia Presenting as Mediastinal Mass-2 Cases.

Rig Vardhan1, Jyoti Kotwal1, Prosenjit Ganguli1, Rehan Ahmed1, Ajay Sharma2, Jasjit Singh2.   

Abstract

Mixed phenotype acute leukemia symbolizes a very small subset of acute leukemia that simply cannot be allocated as lymphoid or myeloid lineage. The 2008 World Health Organisation classification established stringent standard for diagnosis of mixed phenotype acute leukemia, accentuating myeloperoxidase for myeloid lineage, cytoplasmic CD3 for T lineage and CD19 with other B markers for B lineage obligation. Mixed phenotype leukemia is rare and 3-5 % of acute leukmias of all age groups, is associated with poor outcome with overall survival of 18 months. We wish to present two cases of mixed phenotypic acute leukemia who presented with mediastinal masses, were suspected to be T cell lymphoma/leukemia clinically and radiologically. In one case, tissue diagnosis was given as lymphoma for which treatment was given. These cases show that patients diagnosed as lymphoma on histopathology can be cases of mixed phenotype acute leukemia and varying specific treatment protocols and follow up are required. Awareness of these entities will help in proper diagnosis and treatment.

Entities:  

Year:  2015        PMID: 27408360      PMCID: PMC4925536          DOI: 10.1007/s12288-015-0611-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  7 in total

1.  Acute myeloid leukemia presenting as mediastinal mass.

Authors:  Manjusha Nair; P Kusumakumary; P Sindhu Nair
Journal:  Indian J Pediatr       Date:  2013-09-13       Impact factor: 1.967

2.  What is the optimal treatment for biphenotypic acute leukemia?

Authors:  Changcheng Zheng; Jingsheng Wu; Xin Liu; Kaiyang Ding; Xiaoyan Cai; Weibo Zhu
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

3.  Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.

Authors:  Estella Matutes; Winfried F Pickl; Mars Van't Veer; Ricardo Morilla; John Swansbury; Herbert Strobl; Andishe Attarbaschi; Georg Hopfinger; Sue Ashley; Marie Christine Bene; Anna Porwit; Alberto Orfao; Petr Lemez; Richard Schabath; Wolf-Dieter Ludwig
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

4.  Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.

Authors:  O Legrand; J Y Perrot; G Simonin; M Baudard; M Cadiou; C Blanc; S Ramond; F Viguié; J P Marie; R Zittoun
Journal:  Br J Haematol       Date:  1998-01       Impact factor: 6.998

5.  Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.

Authors:  Jeffrey E Rubnitz; Mihaela Onciu; Stanley Pounds; Sheila Shurtleff; Xueyuan Cao; Susana C Raimondi; Frederick G Behm; Dario Campana; Bassem I Razzouk; Raul C Ribeiro; James R Downing; Ching-Hon Pui
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

6.  A close developmental relationship between the lymphoid and myeloid lineages.

Authors:  Hiroshi Kawamoto
Journal:  Trends Immunol       Date:  2006-03-03       Impact factor: 16.687

7.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.